Extracellular angiogenic growth factor interactions: An angiogenesis interactome survey

Endothelium: Journal of Endothelial Cell Research

Volumn 13, Issue 2, 2006, Pages 93-111

  Rustani, Marco ^a   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Angiogenesis; Extracellular matrix; Growth factors; Interactome

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CELL SURFACE RECEPTOR; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBRIN; FIBRINOGEN; FIBRONECTIN; GLYCOSPHINGOLIPID; HEPARIN BINDING PROTEIN; INTEGRIN RECEPTOR; INTERACTOME; INTERLEUKIN 8; LAMININ; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NEUROPILIN; NUCLEOLIN; OSTEONECTIN; PENTRAXIN; PLATELET DERIVED GROWTH FACTOR BB; POLYSACCHARIDE; PROTEOHEPARAN SULFATE; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; DRUG SYNTHESIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANGIOGENIC PROTEINS; ANIMALS; EXTRACELLULAR MATRIX; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 33746802333     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320600698011     Document Type: Review

References (232)

1. Alon, R. and Cahalon, L. and Hershkoviz, R. and Elbaz, D. and Reizis, B. and Wallach, D. and Akiyama, S. and Yamada, K. and Lider, O. (1994) TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein Journal of Immunology, 152, pp. 1304-1313. [CSA]
2. Asplin, I. and Wu, S. and Mathew, S. and Bhattacharjee, G. and Pizzo, S. (2001) Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: Evidence for selective modulation of FGF-2-induced angiogenesis Blood, 97, pp. 3450-3457. [INFOTRIEVE] [CSA] [CROSSREF]
3. Aviezer, D. and Cotton, S. and David, M. and Segev, A. and Khaselev, N. and Galili, N. and Gross, Z. and Yayon, A. (2000) Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis Cancer Research, 60, pp. 2973-2980. [INFOTRIEVE] [CSA]
4. Barillari, G. and Gendelman, R. and Gallo, R. and Ensoli, B. (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence Proceedings of the National Academy of Sciences of the United States of America, 90, pp. 7941-7945. [INFOTRIEVE] [CSA]
5. Barillari, G. and Sgadari, C. and Fiorelli, V. and Samaniego, F. and Colombini, S. and Manzari, V. and Modesti, A. and Nair, B. and Cafaro, A. and Sturzl, M. and (1999a) The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor Blood, 94, pp. 663-672. [INFOTRIEVE] [CSA]
6. Barillari, G. and Sgadari, C. and Palladino, C. and Gendelman, R. and Caputo, A. and Morris, C. and Nair, B. and Markham, P. and Nel, A. and Sturzl, M. and (1999b) Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin Journal of Immunology, 163, pp. 1929-1935. [CSA]
7. Barleon, B. and Siemeister, G. and Martiny-Baron, G. and Weindel, K. and Herzog, C. and Marme, D. (1997) Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells Cancer Research, 57, pp. 5421-5425. [INFOTRIEVE] [CSA]
8. Belotti, D. and Paganoni, P. and Manenti, L. and Garofalo, A. and Marchini, S. and Taraboletti, G. and Giavazzi, R. (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation Cancer Research, 63, pp. 5224-5229. [INFOTRIEVE] [CSA]
9. Bemelmans, M. and Gouma, D. and Buurman, W. (1993) LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma Journal of Immunology, 151, pp. 5554-5562. [CSA]
10. Bergonzoni, L. and Caccia, P. and Cletini, O. and Sarmientos, P. and Isacchi, A. (1992) Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli European Journal of Biochemistry, 210, pp. 823-829. [INFOTRIEVE] [CSA] [CROSSREF]
11. Bhattacharjee, G. and Asplin, I. and Wu, S. and Gawdi, G. and Pizzo, S. (2000) The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding Journal of Biological Chemistry, 275, pp. 26806-26811. [INFOTRIEVE] [CSA]
12. Bikfalvi, A. (2004) Platelet factor 4: An inhibitor of angiogenesis Seminars in Thrombosis and Hemostasis, 30, pp. 379-385. [INFOTRIEVE] [CSA] [CROSSREF]
13. Birkle, S. and Zeng, G. and Gao, L. and Yu, R. and Aubry, J. (2003) Role of tumor-associated gangliosides in cancer progression Biochimie, 85, pp. 455-463. [INFOTRIEVE] [CSA] [CROSSREF]
14. Bolser, D. and Dafas, P. and Harrington, R. and Park, J. and Schroeder, M. (2003) Visualisation and graph-theoretic analysis of a large-scale protein structural interactome BMC Bioinformatics, 4, pp. 45. [INFOTRIEVE] [CSA] [CROSSREF]
15. Bonner, J. and Badgett, A. and Hoffman, M. and Lindroos, P. (1995) Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha 2-macroglobulin is mediated via an alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism Journal of Biological Chemistry, 270, pp. 6389-6395. [INFOTRIEVE] [CSA] [CROSSREF]
16. Bonnet, H. and Filhol, O. and Truchet, I. and Brethenou, P. and Cochet, C. and Amalric, F. and Bouche, G. (1996) Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin Journal of Biological Chemistry, 271, pp. 24781-24787. [INFOTRIEVE] [CSA] [CROSSREF]
17. Borges, E. and Jan, Y. and Ruoslahti, E. (2000) Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain Journal of Biological Chemistry, 275, pp. 39867-39873. [INFOTRIEVE] [CSA] [CROSSREF]
18. Bornstein, P. and Armstrong, L. and Hankenson, K. and Kyriakides, T. and Yang, Z. (2000) Thrombospondin 2, a matricellular protein with diverse functions Matrix Biology, 19, pp. 557-568. [INFOTRIEVE] [CSA] [CROSSREF]
19. Bossard, C. and Van den Berghe, L. and Laurell, H. and Castano, C. and Cerutti, M. and Prats, A. and Prats, H. (2004) Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide Cancer Research, 64, pp. 7507-7512. [INFOTRIEVE] [CSA] [CROSSREF]
20. Bouvard, D. and Brakebusch, C. and Gustafsson, E. and Aszodi, A. and Bengtsson, T. and Berna, A. and Fassler, R. (2001) Functional consequences of integrin gene mutations in mice Circulation Research, 89, pp. 211-223. [INFOTRIEVE] [CSA]
21. Brat, D. and Bellail, A. and Van Meir, E. (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis Neuro-Oncology, 7, pp. 122-133. [INFOTRIEVE] [CSA] [CROSSREF]
22. Brooks, P. and Silletti, S. and von Schalscha, T. and Friedlander, M. and Cheresh, D. (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity Cell, 92, pp. 391-400. [INFOTRIEVE] [CSA] [CROSSREF]
23. Brown, K. and Parish, C. (1994) Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor Biochemistry, 33, pp. 13918-13927. [INFOTRIEVE] [CSA] [CROSSREF]
24. Calabro, L. and Fonsatti, E. and Bellomo, G. and Alonci, A. and Colizzi, F. and Sigalotti, L. and Altomonte, M. and Musolino, C. and Maio, M. (2003) Differential levels of soluble endoglin (CD105) in myeloid malignancies Journal of Cellular Physiology, 194, pp. 171-175. [INFOTRIEVE] [CSA] [CROSSREF]
25. Camenisch, G. and Pisabarro, M. and Sherman, D. and Kowalski, J. and Nagel, M. and Hass, P. and Xie, M. and Gurney, A. and Bodary, S. and Liang, X. and (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo Journal of Biological Chemistry, 277, pp. 17281-17290. [INFOTRIEVE] [CSA] [CROSSREF]
26. Carlson, T. and Feng, Y. and Maisonpierre, P. and Mrksich, M. and Morla, A. (2001) Direct cell adhesion to the angiopoietins mediated by integrins Journal of Biological Chemistry, 276, pp. 26516-26525. [INFOTRIEVE] [CSA] [CROSSREF]
27. Carmeliet, P. and Jain, R. (2000) Angiogenesis in cancer and other diseases Nature, 407, pp. 249-257. [INFOTRIEVE] [CSA] [CROSSREF]
28. Casu, B. and Guerrini, M. and Guglieri, S. and Naggi, A. and Perez, M. and Torri, G. and Cassinelli, G. and Ribatti, D. and Carminati, P. and Giannini, G. and (2004) Undersulfated and glycol-split heparins endowed with antiangiogenic activity Journal of Medicinal Chemistry, 47, pp. 838-848. [INFOTRIEVE] [CSA] [CROSSREF]
29. Catlow, K. and Deakin, J. and Delehedde, M. and Fernig, D. and Gallagher, J. and Pavao, M. and Lyon, M. (2003) Hepatocyte growth factor/ scatter factor and its interaction with heparan sulphate and dermatan sulphate Biochemical Society Transactions, 31, pp. 352-353. [INFOTRIEVE] [CSA] [CROSSREF]
30. Cavallaro, U. and Mariotti, M. and Wu, Z. and Soria, M. and Maier, J. (1997) Fibronectin modulates endothelial response to HIV type 1 Tat AIDS Research and Human Retroviruses, 13, pp. 1341-1348. [INFOTRIEVE] [CSA]
31. Chadderton, N. and Stringer, S. (2003) Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate International Journal of Biochemistry and Cell Biology, 35, pp. 1052-1055. [INFOTRIEVE] [CSA] [CROSSREF]
32. Chang, F. and Li, R. and Ladisch, S. (1997a) Shedding of gangliosides by human medulloblastoma cells Experimental Cell Research, 234, pp. 341-346. [INFOTRIEVE] [CSA] [CROSSREF]
33. Chang, H. and Samaniego, F. and Nair, B. and Buonaguro, L. and Ensoli, B. (1997b) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region AIDS, 11, pp. 1421-1431. [INFOTRIEVE] [CSA]
34. Christian, S. and Pilch, J. and Akerman, M. and Porkka, K. and Laakkonen, P. and Ruoslahti, E. (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels Journal of Cell Biology, 163, pp. 871-878. [INFOTRIEVE] [CSA] [CROSSREF]
35. Coltrini, D. and Rusnati, M. and Zoppetti, G. and Oreste, P. and Grazioli, G. and Naggi, A. and Presta, M. (1994) Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor Biochemical Journal, 303(Pt 2), pp. 583-590. [INFOTRIEVE] [CSA]
36. Comoglio, P. and Boccaccio, C. and Trusolino, L. (2003) Interactions between growth factor receptors and adhesion molecules: Breaking the rules Current Opinion in Cell Biology, 15, pp. 565-571. [INFOTRIEVE] [CSA] [CROSSREF]
37. Conforti, G. and Dominguez-Jimenez, C. and Zanetti, A. and Gimbrone, M., Jr. and Cremona, O. and Marchisio, P. and Dejana, E. (1992) Human endothelial cells express integrin receptors on the luminal aspect of their membrane Blood, 80, pp. 437-446. [INFOTRIEVE] [CSA]
38. Corso, S. and Comoglio, P. and Giordano, S. (2005) Cancer therapy: Can the challenge be MET? Trends in Molecular Medicine, 11, pp. 284-292. [INFOTRIEVE] [CSA] [CROSSREF]
39. Davis, G. and Senger, D. (2005) Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization Circulation Research, 97, pp. 1093-1107. [INFOTRIEVE] [CSA] [CROSSREF]
40. De Marchis, F. and Ribatti, D. and Giampietri, C. and Lentini, A. and Faraone, D. and Scoccianti, M. and Capogrossi, M. and Facchiano, A. (2002) Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor Blood, 99, pp. 2045-2053. [INFOTRIEVE] [CSA] [CROSSREF]
41. Dennis, P. and Saksela, O. and Harpel, P. and Rifkin, D. (1989) Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor Journal of Biological Chemistry, 264, pp. 7210-7216. [INFOTRIEVE] [CSA]
42. Eliceiri, B. (2001) Integrin and growth factor receptor crosstalk Circulation Research, 89, pp. 1104-1110. [INFOTRIEVE] [CSA]
43. Eriksson, A. and Cousens, L. and Weaver, L. and Matthews, B. (1991) Three-dimensional structure of human basic fibroblast growth factor Proceedings of the National Academy of Sciences of the United States of America, 88, pp. 3441-3445. [INFOTRIEVE] [CSA]
44. Feige, J. and Negoescu, A. and Keramidas, M. and Souchelnitskiy, S. and Chambaz, E. (1996) Alpha 2-macroglobulin: A binding protein for transforming growth factor-beta and various cytokines Hormone Research, 45, pp. 227-232. [INFOTRIEVE] [CSA]
45. Fiorelli, V. and Barillari, G. and Toschi, E. and Sgadari, C. and Monini, P. and Sturzl, M. and Ensoli, B. (1999) IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: Implications for AIDS-Kaposi's sarcoma pathogenesis Journal of Immunology, 162, pp. 1165-1170. [CSA]
46. Flaumenhaft, R. and Moscatelli, D. and Rifkin, D. (1990) Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor Journal of Cell Biology, 111, pp. 1651-1659. [INFOTRIEVE] [CSA] [CROSSREF]
47. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine, 1, pp. 27-31. [INFOTRIEVE] [CSA] [CROSSREF]
48. Friedlander, M. and Brooks, P. and Shaffer, R. and Kincaid, C. and Varner, J. and Cheresh, D. (1995) Definition of two angiogenic pathways by distinct alpha v integrins Science, 270, pp. 1500-1502. [INFOTRIEVE] [CSA]
49. Fuh, G. and Garcia, K. and de Vos, A. (2000) The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1 Journal of Biological Chemistry, 275, pp. 26690-26695. [INFOTRIEVE] [CSA]
50. Gagnon, M. and Bielenberg, D. and Gechtman, Z. and Miao, H. and Takashima, S. and Soker, S. and Klagsbrun, M. (2000) Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity Proceedings of the National Academy of Sciences of the United States of America, 97, pp. 2573-2578. [INFOTRIEVE] [CSA] [CROSSREF]
51. Gao, C. and Vande Woude, G. (2005) HGF/SF-Met signaling in tumor progression Cell Research, 15, pp. 49-51. [INFOTRIEVE] [CSA]
52. Gengrinovitch, S. and Berman, B. and David, G. and Witte, L. and Neufeld, G. and Ron, D. (1999) Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165 Journal of Biological Chemistry, 274, pp. 10816-10822. [INFOTRIEVE] [CSA]
53. Gengrinovitch, S. and Greenberg, S. and Cohen, T. and Gitay-Goren, H. and Rockwell, P. and Maione, T. and Levi, B. and Neufeld, G. (1995) Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms Journal of Biological Chemistry, 270, pp. 15059-15065. [INFOTRIEVE] [CSA] [CROSSREF]
54. Goerges, A. and Nugent, M. (2003) Regulation of vascular endothelial growth factor binding and activity by extracellular pH Journal of Biological Chemistry, 278, pp. 19518-19525. [INFOTRIEVE] [CSA] [CROSSREF]
55. Goerges, A. and Nugent, M. (2004) pH regulates vascular endothelial growth factor binding to fibronectin: A mechanism for control of extracellular matrix storage and release Journal of Biological Chemistry, 279, pp. 2307-2315. [INFOTRIEVE] [CSA] [CROSSREF]
56. Gohring, W. and Sasaki, T. and Heldin, C. and Timpl, R. (1998) Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope European Journal of Biochemistry, 255, pp. 60-66. [INFOTRIEVE] [CSA] [CROSSREF]
57. Gospodarowicz, D. and Cheng, J. (1986) Heparin protects basic and acidic FGF from inactivation Journal of Cellular Physiology, 128, pp. 475-484. [INFOTRIEVE] [CSA] [CROSSREF]
58. Gupta, K. and Gupta, P. and Wild, R. and Ramakrishnan, S. and Hebbel, R. (1999) Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis Angiogenesis, 3, pp. 147-158. [INFOTRIEVE] [CSA] [CROSSREF]
59. Halden, Y. and Rek, A. and Atzenhofer, W. and Szilak, L. and Wabnig, A. and Kungl, A. (2004) Interleukin-8 binds to syndecan-2 on human endothelial cells Biochemical Journal, 377, pp. 533-538. [INFOTRIEVE] [CSA] [CROSSREF]
60. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell, 86, pp. 353-364. [INFOTRIEVE] [CSA] [CROSSREF]
61. Handsley, M. and Edwards, D. (2005) Metalloproteinases and their inhibitors in tumor angiogenesis International Journal of Cancer, 115, pp. 849-860. [CSA] [CROSSREF]
62. Hanneken, A. and Baird, A. (1995) Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid Investigative Ophthalmology and Visual Science, 36, pp. 1192-1196. [INFOTRIEVE] [CSA]
63. Hanneken, A. and Maher, P. and Baird, A. (1995) High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells-implications for the modulation of FGF-2 Journal of Cell Biology, 128, pp. 1221-1228. [INFOTRIEVE] [CSA] [CROSSREF]
64. Hayashi, K. and Madri, J. and Yurchenco, P. (1992) Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: An adhesion modulated by glycosaminoglycan Journal of Cell Biology, 119, pp. 945-959. [INFOTRIEVE] [CSA] [CROSSREF]
65. Hendriks, J. and Planelles, L. and de Jong-Odding, J. and Hardenberg, G. and Pals, S. and Hahne, M. and Spaargaren, M. and Medema, J. (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation Cell Death and Differentiation, 12, pp. 637-648. [INFOTRIEVE] [CSA] [CROSSREF]
66. Heroult, M. and Bernard-Pierrot, I. and Delbe, J. and Hamma-Kourbali, Y. and Katsoris, P. and Barritault, D. and Papadimitriou, E. and Plouet, J. and Courty, J. (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis Oncogene, 23, pp. 1745-1753. [INFOTRIEVE] [CSA] [CROSSREF]
67. Hogg, P. and Hotchkiss, K. and Jimenez, B. and Stathakis, P. and Chesterman, C. (1997) Interaction of platelet-derived growth factor with thrombospondin 1 Biochemical Journal, 326(Pt 3), pp. 709-716. [INFOTRIEVE] [CSA]
68. Hornig, C. and Barleon, B. and Ahmad, S. and Vuorela, P. and Ahmed, A. and Weich, H. (2000) Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids Laboratory Investigation, 80, pp. 443-454. [INFOTRIEVE] [CSA]
69. Hsia, E. and Richardson, T. and Nugent, M. (2003) Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling Journal of Cellular Biochemistry, 88, pp. 1214-1225. [INFOTRIEVE] [CSA] [CROSSREF]
70. Hutchings, H. and Ortega, N. and Plouet, J. (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation Faseb Journal, 17, pp. 1520-1522. [INFOTRIEVE] [CSA]
71. Inoki, I. and Shiomi, T. and Hashimoto, G. and Enomoto, H. and Nakamura, H. and Makino, K. and Ikeda, E. and Takata, S. and Kobayashi, K. and Okada, Y. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis Faseb Journal, 16, pp. 219-221. [INFOTRIEVE] [CSA]
72. Iozzo, R. and San Antonio, J. (2001) Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena Journal of Clinical Investigation, 108, pp. 349-355. [INFOTRIEVE] [CSA] [CROSSREF]
73. Iruela-Arispe, M. and Lombardo, M. and Krutzsch, H. and Lawler, J. and Roberts, D. (1999) Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats Circulation, 100, pp. 1423-1431. [INFOTRIEVE] [CSA]
74. Jia, H. and Lohr, M. and Jezequel, S. and Davis, D. and Shaikh, S. and Selwood, D. and Zachary, I. (2001) Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis Biochemical and Biophysical Research Communications, 283, pp. 469-479. [INFOTRIEVE] [CSA] [CROSSREF]
75. Jouan, V. and Canron, X. and Alemany, M. and Caen, J. and Quentin, G. and Plouet, J. and Bikfalvi, A. (1999) Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action Blood, 94, pp. 984-993. [INFOTRIEVE] [CSA]
76. Ju, B. and Park, B. and Park, J. and Han, K. (2003) Visualization and analysis of protein interactions Bioinformatics, 19, pp. 317-318. [INFOTRIEVE] [CSA] [CROSSREF]
77. Kanematsu, A. and Marui, A. and Yamamoto, S. and Ozeki, M. and Hirano, Y. and Yamamoto, M. and Ogawa, O. and Komeda, M. and Tabata, Y. (2004) Type I collagen can function as a reservoir of basic fibroblast growth factor Journal of Control Release, 99, pp. 281-292. [CSA] [CROSSREF]
78. Kato, S. and Ishii, T. and Hara, H. and Sugiura, N. and Kimata, K. and Akamatsu, N. (1994) Hepatocyte growth factor immobilized onto culture substrates through heparin and matrigel enhances DNA synthesis in primary rat hepatocytes Experimental Cell Research, 211, pp. 53-58. [INFOTRIEVE] [CSA] [CROSSREF]
79. Kemeny, L. and Szolnoky, G. and Kenderessy, A. and Gyulai, R. and Kiss, M. and Michel, G. and Nagy, K. and Ruzicka, T. and Dobozy, A. (1998) Identification of a soluble interleukin-8 inhibitor in the supernatant of polymorphonuclear leukocytes Immunology Letters, 64, pp. 23-29. [INFOTRIEVE] [CSA] [CROSSREF]
80. Kendall, R. and Wang, G. and Thomas, K. (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR Biochemical and Biophysical Research Communications, 226, pp. 324-328. [INFOTRIEVE] [CSA] [CROSSREF]
81. Kessler, O. and Shraga-Heled, N. and Lange, T. and Gutmann-Raviv, N. and Sabo, E. and Baruch, L. and Machluf, M. and Neufeld, G. (2004) Semaphorin-3F is an inhibitor of tumor angiogenesis Cancer Research, 64, pp. 1008-1015. [INFOTRIEVE] [CSA] [CROSSREF]
82. Kim, Y. and Hwang, S. and Pyun, B. and Kim, T. and Lee, S. and Gho, Y. and Kwon, Y. (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1 Journal of Biological Chemistry, 277, pp. 27872-27879. [INFOTRIEVE] [CSA] [CROSSREF]
83. Kobayashi, T. and Honke, K. and Miyazaki, T. and Matsumoto, K. and Nakamura, T. and Ishizuka, I. and Makita, A. (1994) Hepatocyte growth factor specifically binds to sulfoglycolipids Journal of Biological Chemistry, 269, pp. 9817-9821. [INFOTRIEVE] [CSA]
84. Kojima, T. and Katsumi, A. and Yamazaki, T. and Muramatsu, T. and Nagasaka, T. and Ohsumi, K. and Saito, H. (1996) Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor Journal of Biological Chemistry, 271, pp. 5914-5920. [INFOTRIEVE] [CSA] [CROSSREF]
85. Koochekpour, S. and Merzak, A. and Pilkington, G. (1996) Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro Cancer Letters, 102, pp. 209-215. [INFOTRIEVE] [CSA] [CROSSREF]
86. Kumar, C. (2003) Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis Current Drug Targets, 4, pp. 123-131. [INFOTRIEVE] [CSA] [CROSSREF]
87. Kumar, C. and Malkowski, M. and Yin, Z. and Tanghetti, E. and Yaremko, B. and Nechuta, T. and Varner, J. and Liu, M. and Smith, E. and Neustadt, B. and (2001) Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist Cancer Research, 61, pp. 2232-2238. [INFOTRIEVE] [CSA]
88. Kupprion, C. and Motamed, K. and Sage, E. (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells Journal of Biological Chemistry, 273, pp. 29635-29640. [INFOTRIEVE] [CSA] [CROSSREF]
89. Kurdowska, A. and Alden, S. and Noble, J. and Stevens, M. and Carr, F. (2000) Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2-macroglobulin complexes by human alveolar macrophages Cytokine, 12, pp. 1046-1053. [INFOTRIEVE] [CSA] [CROSSREF]
90. Kurosawa, N. and Kadomatsu, K. and Ikematsu, S. and Sakuma, S. and Kimura, T. and Muramatsu, T. (2000) Midkine binds specifically to sulfatide the role of sulfatide in cell attachment to midkine-coated surfaces European Journal of Biochemistry, 267, pp. 344-351. [INFOTRIEVE] [CSA] [CROSSREF]
91. LaMarre, J. and Wollenberg, G. and Gonias, S. and Hayes, M. (1991) Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins Laboratory Investigation, 65, pp. 3-14. [INFOTRIEVE] [CSA]
92. Lamszus, K. and Joseph, A. and Jin, L. and Yao, Y. and Chowdhury, S. and Fuchs, A. and Polverini, P. and Goldberg, I. and Rosen, E. (1996) Scatter factor binds to thrombospondin and other extracellular matrix components American Journal of Pathology, 149, pp. 805-819. [INFOTRIEVE] [CSA]
93. Lang, Z. and Guerrera, M. and Li, R. and Ladisch, S. (2001) Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration Biochemical and Biophysical Research Communication, 282, pp. 1031-1037. [CSA] [CROSSREF]
94. Lantz, M. and Thysell, H. and Nilsson, E. and Olsson, I. (1991) On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin Journal of Clinical Investigation, 88, pp. 2026-2031. [INFOTRIEVE] [CSA]
95. Leali, D. and Belleri, M. and Urbinati, C. and Coltrini, D. and Oreste, P. and Zoppetti, G. and Ribatti, D. and Rusnati, M. and Presta, M. (2001) Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives Journal of Biological Chemistry, 276, pp. 37900-37908. [INFOTRIEVE] [CSA]
96. Lebrin, F. and Deckers, M. and Bertolino, P. and Ten Dijke, P. (2005) TGF-beta receptor function in the endothelium Cardiovascular Research, 65, pp. 599-608. [INFOTRIEVE] [CSA] [CROSSREF]
97. Li, Z. and Shimada, Y. and Uchida, S. and Maeda, M. and Kawabe, A. and Mori, A. and Itami, A. and Kano, M. and Watanabe, G. and Imamura, M. (2000) TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma International Journal of Oncology, 17, pp. 453-460. [INFOTRIEVE] [CSA]
98. Lietha, D. and Chirgadze, D. and Mulloy, B. and Blundell, T. and Gherardi, E. (2001) Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor EMBO Journal, 20, pp. 5543-5555. [INFOTRIEVE] [CSA] [CROSSREF]
99. Lin, P. and Buxton, J. and Acheson, A. and Radziejewski, C. and Maisonpierre, P. and Yancopoulos, G. and Channon, K. and Hale, L. and Dewhirst, M. and George, S. and (1998) Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2 Proceedings of the National Academy of Sciences of the United States of America, 95, pp. 8829-8834. [INFOTRIEVE] [CSA] [CROSSREF]
100. Lindahl, U. and Lidholt, K. and Spillmann, D. and Kjellen, L. (1994) More to "heparin" than anticoagulation Thrombosis Research, 75, pp. 1-32. [INFOTRIEVE] [CSA] [CROSSREF]
101. Liu, Y. and Jones, M. and Hingtgen, C. and Bu, G. and Laribee, N. and Tanzi, R. and Moir, R. and Nath, A. and He, J. (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands Nature Medicine, 6, pp. 1380-1387. [INFOTRIEVE] [CSA] [CROSSREF]
102. Lopez-Casillas, F. and Cheifetz, S. and Doody, J. and Andres, J. and Lane, W. and Massague, J. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system Cell, 67, pp. 785-795. [INFOTRIEVE] [CSA]
103. Lowe-Krentz, L. and Thompson, K. and Patton, W., 2nd. (1992) Heparin releasable and nonreleasable forms of heparan sulfate proteoglycan are found on the surfaces of cultured porcine aortic endothelial cells Molecular and Celluar Biochemistry, 109, pp. 51-60. [CSA]
104. Lozano, R. and Redondo-Horcajo, M. and Jimenez, M. and Zilberberg, L. and Cuevas, P. and Bikfalvi, A. and Rico, M. and Gimenez-Gallego, G. (2001) Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity Journal of Biological Chemistry, 276, pp. 35723-35734. [INFOTRIEVE] [CSA] [CROSSREF]
105. Luque, A. and Carpizo, D. and Iruela-Arispe, M. (2003) ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165 Journal of Biological Chemistry, 278, pp. 23656-23665. [INFOTRIEVE] [CSA] [CROSSREF]
106. Lyon, M. and Deakin, J. and Mizuno, K. and Nakamura, T. and Gallagher, J. (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants Journal of Biological Chemistry, 269, pp. 11216-11223. [INFOTRIEVE] [CSA]
107. Lyon, M. and Deakin, J. and Rahmoune, H. and Fernig, D. and Nakamura, T. and Gallagher, J. (1998) Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate Journal of Biological Chemistry, 273, pp. 271-278. [INFOTRIEVE] [CSA] [CROSSREF]
108. Lyon, M. and Rushton, G. and Gallagher, J. (1997) The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific Journal of Biological Chemistry, 272, pp. 18000-18006. [INFOTRIEVE] [CSA] [CROSSREF]
109. Marchio, S. and Alfano, M. and Primo, L. and Gramaglia, D. and Butini, L. and Gennero, L. and De Vivo, E. and Arap, W. and Giacca, M. and Pasqualini, R. and (2005) Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein Blood, 105, pp. 2802-2811. [INFOTRIEVE] [CSA] [CROSSREF]
110. Margosio, B. and Marchetti, D. and Vergani, V. and Giavazzi, R. and Rusnati, M. and Presta, M. and Taraboletti, G. (2003) Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2 Blood, 102, pp. 4399-4406. [INFOTRIEVE] [CSA] [CROSSREF]
111. Maroder, M. and Scarpa, S. and Screpanti, I. and Stigliano, A. and Meco, D. and Vacca, A. and Stuppia, L. and Frati, L. and Modesti, A. and Gulino, A. (1996) Human immunodeficiency virus type 1 tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development Cellular Immunology, 168, pp. 49-58. [INFOTRIEVE] [CSA] [CROSSREF]
112. Marshall, L. and Perks, B. and Ferkol, T. and Shute, J. (2001) IL-8 released constitutively by primary bronchial epithelial cells in culture forms an inactive complex with secretory component Journal of Immunology, 167, pp. 2816-2823. [CSA]
113. Mawatari, K. and Liu, B. and Kent, K. (2000) Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction Journal of Vascular Surgery, 31, pp. 375-381. [INFOTRIEVE] [CSA] [CROSSREF]
114. McArthur, C. and Wang, Y. and Heruth, D. and Gustafson, S. (2001) Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53 Archives of Oral Biol, 46, pp. 545-555. [CSA] [CROSSREF]
115. Caffrey, T. and Falcone, D. and Vicente, D. and Du, B. and Consigli, S. and Borth, W. (1994) Protection of transforming growth factor-beta 1 activity by heparin and fucoidan Journal of Cellular Physiology, 159, pp. 51-59. [CSA] [CROSSREF]
116. Michieli, P. and Mazzone, M. and Basilico, C. and Cavassa, S. and Sottile, A. and Naldini, L. and Comoglio, P. (2004) Targeting the tumor and its microenvironment by a dual-function decoy Met receptor Cancer Cell, 6, pp. 61-73. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
117. Migdal, M. and Huppertz, B. and Tessler, S. and Comforti, A. and Shibuya, M. and Reich, R. and Baumann, H. and Neufeld, G. (1998) Neuropilin-1 is a placenta growth factor-2 receptor Journal of Biological Chemistry, 273, pp. 22272-22278. [INFOTRIEVE] [CSA] [CROSSREF]
118. Mignatti, P. and Rifkin, D. (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis Enzyme Protein, 49, pp. 117-137. [INFOTRIEVE] [CSA]
119. Miralem, T. and Steinberg, R. and Price, D. and Avraham, H. (2001) VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells Oncogene, 20, pp. 5511-5524. [INFOTRIEVE] [CSA] [CROSSREF]
120. Mitola, S. and Soldi, R. and Zanon, I. and Barra, L. and Gutierrez, M. and Berkhout, B. and Giacca, M. and Bussolino, F. (2000) Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells Journal of Virology, 74, pp. 344-353. [INFOTRIEVE] [CSA]
121. Mooradian, D. and Lucas, R. and Weatherbee, J. and Furcht, L. (1989) Transforming growth factor-beta 1 binds to immobilized fibronectin Journal of Cellular Biochemistry, 41, pp. 189-200. [INFOTRIEVE] [CSA] [CROSSREF]
122. Moroianu, J. and Riordan, J. (1994) Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity Proceedings of the National Academy of Sciences of the United States of America, 91, pp. 1677-1681. [INFOTRIEVE] [CSA]
123. Munger, J. and Harpel, J. and Giancotti, F. and Rifkin, D. (1998) Interactions between growth factors and integrins: Latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1 Molecular Biology of the Cell, 9, pp. 2627-2638. [INFOTRIEVE] [CSA]
124. Munger, J. and Huang, X. and Kawakatsu, H. and Griffiths, M. and Dalton, S. and Wu, J. and Pittet, J. and Kaminski, N. and Garat, C. and Matthay, M. and (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis Cell, 96, pp. 319-328. [INFOTRIEVE] [CSA] [CROSSREF]
125. Muramatsu, H. and Zou, K. and Sakaguchi, N. and Ikematsu, S. and Sakuma, S. and Muramatsu, T. (2000) LDL receptor-related protein as a component of the midkine receptor Biochemical and Biophysical Research Communications, 270, pp. 936-941. [INFOTRIEVE] [CSA] [CROSSREF]
126. Muramatsu, H. and Zou, P. and Suzuki, H. and Oda, Y. and Chen, G. and Sakaguchi, N. and Sakuma, S. and Maeda, N. and Noda, M. and Takada, Y. and (2004) alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor Journal of Cell Science, 117, pp. 5405-5415. [INFOTRIEVE] [CSA] [CROSSREF]
127. Murphy-Ullrich, J. and Schultz-Cherry, S. and Hook, M. (1992) Transforming growth factor-beta complexes with thrombospondin Molecular Biology of the Cell, 3, pp. 181-188. [INFOTRIEVE] [CSA]
128. Naldini, A. and Carraro, F. (2005) Role of inflammatory mediators in angiogenesis Current Drug Targets in Inflammation and Allergy, 4, pp. 3-8. [CSA] [CROSSREF]
129. Nesmelova, I. and Sham, Y. and Dudek, A. and van Eijk, L. and Wu, G. and Slungaard, A. and Mortari, F. and Griffioen, A. and Mayo, K. (2005) Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level Journal of Biological Chemistry, 280, pp. 4948-4958. [INFOTRIEVE] [CSA] [CROSSREF]
130. Neufeld, G. and Cohen, T. and Shraga, N. and Lange, T. and Kessler, O. and Herzog, Y. (2002a) The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis Trends in Cardiovascular Medicine, 12, pp. 13-19. [INFOTRIEVE] [CSA] [CROSSREF]
131. Neufeld, G. and Kessler, O. and Herzog, Y. (2002b) The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF Advances in Experimental Medicine and Biology, 515, pp. 81-90. [INFOTRIEVE] [CSA]
132. Norrby, K. (2000) 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis International Journal of Experimental Pathology, 81, pp. 191-198. [INFOTRIEVE] [CSA] [CROSSREF]
133. Nyberg, P. and Xie, L. and Kalluri, R. (2005) Endogenous inhibitors of angiogenesis Cancer Research, 65, pp. 3967-3979. [INFOTRIEVE] [CSA] [CROSSREF]
134. O'Connor-McCourt, M. and Wakefield, L. (1987) Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin Journal of Biological Chemisty, 262, pp. 14090-14099. [CSA]
135. Ogawa, T. and Takayama, K. and Takakura, N. and Kitano, S. and Ueno, H. (2002) Anti-tumor angiogenesis therapy using soluble receptors: Enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor Cancer and Gene Therapy, 9, pp. 633-640. [CSA] [CROSSREF]
136. Orlev, N. and Shamir, R. and Shiloh, Y. (2004) PIVOT: Protein interacions visualization tool Bioinformatics, 20, pp. 424-425. [INFOTRIEVE] [CSA] [CROSSREF]
137. Ostman, A. (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma Cytokine and Growth Factor Reviews, 15, pp. 275-286. [INFOTRIEVE] [CSA] [CROSSREF]
138. Papaconstantinou, M. and Carrell, C. and Pineda, A. and Bobofchak, K. and Mathews, F. and Flordellis, C. and Maragoudakis, M. and Tsopanoglou, N. and Di Cera, E. (2005) Thrombin functions through its RGD sequence in a non-canonical conformation Journal of Biological Chemistry, 280, pp. 29393-29396. [INFOTRIEVE] [CSA] [CROSSREF]
139. Park, D. and Lee, S. and Bolser, D. and Schroeder, M. and Lappe, M. and Oh, D. and Bhak, J. (2005) Comparative interactomics analysis of protein family interaction networks using PSIMAP (protein structural interactome map) Bioinformatics, 21, pp. 3234-3240. [INFOTRIEVE] [CSA] [CROSSREF]
140. Park, J. and Keller, G. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Molecular Biology of the Cell, 4, pp. 1317-1326. [INFOTRIEVE] [CSA]
141. Patterson, A. and Gardner, L. and Shaw, J. and David, G. and Loreau, E. and Aguilar, L. and Ashton, B. and Middleton, J. (2005) Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium Arthritis and Rheumatism, 52, pp. 2331-2342. [INFOTRIEVE] [CSA] [CROSSREF]
142. Pellegrini, L. (2001) Role of heparan sulfate in fibroblast growth factor signalling: A structural view Current Opinion in Structural Biology, 11, pp. 629-634. [INFOTRIEVE] [CSA] [CROSSREF]
143. Perollet, C. and Han, Z. and Savona, C. and Caen, J. and Bikfalvi, A. (1998) Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization Blood, 91, pp. 3289-3299. [INFOTRIEVE] [CSA]
144. Pisano, C. and Aulicino, C. and Vesci, L. and Casu, B. and Naggi, A. and Torri, G. and Ribatti, D. and Belleri, M. and Rusnati, M. and Presta, M. (2005) Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist Glycobiology, 15, pp. 1C-6C. [INFOTRIEVE] [CSA] [CROSSREF]
145. Plank, M. and Sleeman, B. and Jones, P. (2004) The role of the angiopoietins in tumour angiogenesis Growth Factors, 22, pp. 1-11. [INFOTRIEVE] [CSA] [CROSSREF]
146. Polykratis, A. and Delbe, J. and Courty, J. and Papadimitriou, E. and Katsoris, P. (2004) Identification of heparin affin regulatory peptide domains with potential role on angiogenesis International Journal of Biochemistry and Cell Biology, 36, pp. 1954-1966. [INFOTRIEVE] [CSA] [CROSSREF]
147. Presta, M. and Dell'Era, P. and Mitola, S. and Moroni, E. and Ronca, R. and Rusnati, M. (2005a) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine and Growth Factor Reviews, 16, pp. 159-178. [INFOTRIEVE] [CSA] [CROSSREF]
148. Presta, M. and Leali, D. and Stabile, H. and Ronca, R. and Camozzi, M. and Coco, L. and Moroni, E. and Liekens, S. and Rusnati, M. (2003) Heparin derivatives as angiogenesis inhibitors Current Pharmaceutical Design, 9, pp. 553-566. [INFOTRIEVE] [CSA] [CROSSREF]
149. Presta, M. and Maier, J. and Rusnati, M. and Ragnotti, G. (1989) Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form Journal of Cell Physiology, 140, pp. 68-74. [CSA] [CROSSREF]
150. Presta, M. and Oreste, P. and Zoppetti, G. and Belleri, M. and Tanghetti, E. and Leali, D. and Urbinati, C. and Bugatti, A. and Ronca, R. and Nicoli, S. and (2005b) Antiangiogenic activity of semisynthetic biotechnological heparins. Low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists Arteriosclerosis, Thrombosis, and Vascular Biology, 25, pp. 71-76. [INFOTRIEVE] [CSA]
151. Presta, M. and Rusnati, M. and Urbinati, C. and Sommer, A. and Ragnotti, G. (1991a) Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): Identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells Journal of Cell Physiology, 149, pp. 512-524. [CSA] [CROSSREF]
152. Presta, M. and Rusnati, M. and Urbinati, C. and Statuto, M. and Ragnotti, G. (1991b) Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF Annals of the New York Academy of Sciences, 638, pp. 361-368. [INFOTRIEVE] [CSA]
153. Presta, M. and Rusnati, M. and Urbinati, C. and Tanghetti, E. and Statuto, M. and Pozzi, A. and Gualandris, A. and Ragnotti, G. (1992) Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells EXS, 61, pp. 205-209. [INFOTRIEVE] [CSA]
154. Rahman, S. and Patel, Y. and Murray, J. and Patel, K. and Sumathipala, R. and Sobel, M. and Wijelath, E. (2005) Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells BMC Cell Biology, 6, pp. 8. [INFOTRIEVE] [CSA]
155. Raines, E. and Lane, T. and Iruela-Arispe, M. and Ross, R. and Sage, E. (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 1281-1285. [INFOTRIEVE] [CSA]
156. Raines, E. and Ross, R. (1992) Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences Journal of Cell Biology, 116, pp. 533-543. [INFOTRIEVE] [CSA] [CROSSREF]
157. Reis, R. and Schuppan, D. and Barreto, A. and Bauer, M. and Bork, J. and Hassler, G. and Coelho-Sampaio, T. (2005) Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans Biochemical and Biophysical Research Communications, 333, pp. 976-983. [INFOTRIEVE] [CSA] [CROSSREF]
158. Ribatti, D. (2005) The crucial role of vascular permeability factor/ vascular endothelial growth factor in angiogenesis: A historical review British Journal of Haematology, 128, pp. 303-309. [INFOTRIEVE] [CSA] [CROSSREF]
159. Ribatti, D. and Leali, D. and Vacca, A. and Giuliani, R. and Gualandris, A. and Roncali, L. and Nolli, M. and Presta, M. (1999) In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2 Journal of Cell Science, 112(Pt 23), pp. 4213-4221. [INFOTRIEVE] [CSA]
160. Robinson, C. and Stringer, S. (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors Journal of Cell Science, 114, pp. 853-865. [INFOTRIEVE] [CSA]
161. Roeckl, W. and Hecht, D. and Sztajer, H. and Waltenberger, J. and Yayon, A. and Weich, H. (1998) Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2 Experimental Cell Research, 241, pp. 161-170. [INFOTRIEVE] [CSA] [CROSSREF]
162. Ruegg, C. and Mariotti, A. (2003) Vascular integrins: Pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis Cellular and Molecular Life Sciences, 60, pp. 1135-1157. [INFOTRIEVE] [CSA]
163. Rusnati, M. and Camozzi, M. and Moroni, E. and Bottazzi, B. and Peri, G. and Indraccolo, S. and Amadori, A. and Mantovani, A. and Presta, M. (2004) Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis Blood, 104, pp. 92-99. [INFOTRIEVE] [CSA] [CROSSREF]
164. Rusnati, M. and Coltrini, D. and Oreste, P. and Zoppetti, G. and Albini, A. and Noonan, D. and d'Adda di Fagagna, F. and Giacca, M. and Presta, M. (1997a) Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size Journal of Biological Chemistry, 272, pp. 11313-11320. [INFOTRIEVE] [CSA] [CROSSREF]
165. Rusnati, M. and Oreste, P. and Zoppetti, G. and Presta, M. (2005) Biotechnological engineering of heparin/heparan sulphate: A novel area of multi-target drug discovery Current Pharmaceutical Design, 11, pp. 2489-2499. [INFOTRIEVE] [CSA] [CROSSREF]
166. Rusnati, M. and Presta, M. (1996) Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization International Journal of Clinical Laboratory Research, 26, pp. 15-23. [INFOTRIEVE] [CSA]
167. Rusnati, M. and Tanghetti, E. and Dell'Era, P. and Gualandris, A. and Presta, M. (1997b) alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells Molecular Biology of the Cell, 8, pp. 2449-2461. [INFOTRIEVE] [CSA]
168. Rusnati, M. and Tanghetti, E. and Urbinati, C. and Tulipano, G. and Marchesini, S. and Ziche, M. and Presta, M. (1999a) Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: Biochemical characterization and biological consequences in endothelial cell cultures Molecular Biology of the Cell, 10, pp. 313-327. [INFOTRIEVE] [CSA]
169. Rusnati, M. and Taraboletti, G. and Urbinati, C. and Tulipano, G. and Giuliani, R. and Molinari-Tossatti, M. and Sennino, B. and Giacca, M. and Tyagi, M. and Albini, A. and (2000) Thrombospondin-1/HIV-1 tat protein interaction: Modulation of the biological activity of extracellular Tat FASEB Journal, 14, pp. 1917-1930. [INFOTRIEVE] [CSA] [CROSSREF]
170. Rusnati, M. and Tulipano, G. and Spillmann, D. and Tanghetti, E. and Oreste, P. and Zoppetti, G. and Giacca, M. and Presta, M. (1999b) Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides Journal of Biological Chemistry, 274, pp. 28198-28205. [INFOTRIEVE] [CSA] [CROSSREF]
171. Rusnati, M. and Tulipano, G. and Urbinati, C. and Tanghetti, E. and Giuliani, R. and Giacca, M. and Ciomei, M. and Corallini, A. and Presta, M. (1998) The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists Journal of Biological Chemistry, 273, pp. 16027-16037. [INFOTRIEVE] [CSA] [CROSSREF]
172. Rusnati, M. and Urbinati, C. and Caputo, A. and Possati, L. and Lortat-Jacob, H. and Giacca, M. and Ribatti, D. and Presta, M. (2001) Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat Journal of Biological Chemistry, 276, pp. 22420-22425. [INFOTRIEVE] [CSA] [CROSSREF]
173. Rusnati, M. and Urbinati, C. and Presta, M. (1993) Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors Journal of Cellular Physiology, 154, pp. 152-161. [INFOTRIEVE] [CSA] [CROSSREF]
174. Rusnati, M. and Urbinati, C. and Tanghetti, E. and Dell'Era, P. and Lortat-Jacob, H. and Presta, M. (2002) Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2 Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 4367-4372. [INFOTRIEVE] [CSA] [CROSSREF]
175. Russo, K. and Ragone, R. and Facchiano, A. and Capogrossi, M. and Facchiano, A. (2002) Platelet-derived growth factor-BB and basic fibroblast growth factor directly interact in vitro with high affinity Journal of Biological Chemistry, 277, pp. 1284-1291. [INFOTRIEVE] [CSA] [CROSSREF]
176. Sachinidis, A. and Kraus, R. and Seul, C. and Meyer zu Brickwedde, M. and Schulte, K. and Ko, Y. and Hoppe, J. and Vetter, H. (1996) Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms European Journal of Cell Biology, 71, pp. 79-88. [INFOTRIEVE] [CSA]
177. Sahni, A. and Altland, O. and Francis, C. (2003) FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth Journal of Thrombosis and Haemostasis, 1, pp. 1304-1310. [INFOTRIEVE] [CSA] [CROSSREF]
178. Sahni, A. and Francis, C. (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation Blood, 96, pp. 3772-3778. [INFOTRIEVE] [CSA]
179. Sahni, A. and Francis, C. (2004) Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alpha v beta3 Blood, 104, pp. 3635-3641. [INFOTRIEVE] [CSA] [CROSSREF]
180. Sahni, A. and Sahni, S. and Simpson-Haidaris, P. and Francis, C. (2004) Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells Journal of Thrombosis and Haemostasis, 2, pp. 1629-1636. [INFOTRIEVE] [CSA] [CROSSREF]
181. Said, E. and Courty, J. and Svab, J. and Delbe, J. and Krust, B. and Hovanessian, A. (2005) Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin FEBS Journal, 272, pp. 4646-4659. [INFOTRIEVE] [CSA] [CROSSREF]
182. Sakata, H. and Stahl, S. and Taylor, W. and Rosenberg, J. and Sakaguchi, K. and Wingfield, P. and Rubin, J. (1997) Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling Journal of Biological Chemistry, 272, pp. 9457-9463. [INFOTRIEVE] [CSA] [CROSSREF]
183. Salmivirta, M. and Heino, J. and Jalkanen, M. (1992) Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth Journal of Biological Chemistry, 267, pp. 17606-17610. [INFOTRIEVE] [CSA]
184. Sandhoff, R. and Grieshaber, H. and Djafarzadeh, R. and Sijmonsma, T. and Proudfoot, A. and Handel, T. and Wiegandt, H. and Nelson, P. and Grone, H. (2005) Chemokines bind to sulfatides as revealed by surface plasmon resonance Biochimica et Biophysica Acta, 1687, pp. 52-63. [INFOTRIEVE] [CSA]
185. Schoppet, M. and Chavakis, T. and Al-Fakhri, N. and Kanse, S. and Preissner, K. (2002) Molecular interactions and functional interference between vitronectin and transforming growth factor-beta Laboratory Investigation, 82, pp. 37-46. [INFOTRIEVE] [CSA]
186. Schuch, G. and Machluf, M. and Bartsch, G., Jr. and Nomi, M. and Richard, H. and Atala, A. and Soker, S. (2002) In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo Blood, 100, pp. 4622-4628. [INFOTRIEVE] [CSA] [CROSSREF]
187. Schuppan, D. and Schmid, M. and Somasundaram, R. and Ackermann, R. and Ruehl, M. and Nakamura, T. and Riecken, E. (1998) Collagens in the liver extracellular matrix bind hepatocyte growth factor Gastroenterology, 114, pp. 139-152. [INFOTRIEVE] [CSA] [CROSSREF]
188. Serini, G. and Valdembri, D. and Zanivan, S. and Morterra, G. and Burkhardt, C. and Caccavari, F. and Zammataro, L. and Primo, L. and Tamagnone, L. and Logan, M. and (2003) Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function Nature, 424, pp. 391-397. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
189. Shoyab, M. and McDonald, V. and Byles, C. and Todaro, G. and Plowman, G. (1990) Epithelins 1 and 2: Isolation and characterization of two cysteine-rich growth-modulating proteins Proceedings of the National Academy of Sciences of the United States of America, 87, pp. 7912-7916. [INFOTRIEVE] [CSA]
190. Simons, M. and Horowitz, A. (2001) Syndecan-4-mediated signalling Cell Signaling, 13, pp. 855-862. [CSA] [CROSSREF]
191. Soker, S. and Goldstaub, D. and Svahn, C. and Vlodavsky, I. and Levi, B. and Neufeld, G. (1994) Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors Biochemistry and Biophysics Research Communication, 203, pp. 1339-1347. [CSA] [CROSSREF]
192. Soker, S. and Miao, H. and Nomi, M. and Takashima, S. and Klagsbrun, M. (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding Journal of Cellular Biochemistry, 85, pp. 357-368. [INFOTRIEVE] [CSA] [CROSSREF]
193. Soker, S. and Takashima, S. and Miao, H. and Neufeld, G. and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell, 92, pp. 735-745. [INFOTRIEVE] [CSA] [CROSSREF]
194. Soncin, F. (1992) Angiogenin supports endothelial and fibroblast cell adhesion Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 2232-2236. [INFOTRIEVE] [CSA]
195. Soncin, F. and Strydom, D. and Shapiro, R. (1997) Interaction of heparin with human angiogenin Journal of Biological Chemistry, 272, pp. 9818-9824. [INFOTRIEVE] [CSA] [CROSSREF]
196. Spillmann, D. and Witt, D. and Lindahl, U. (1998) Defining the interleukin-8-binding domain of heparan sulfate Journal of Biological Chemistry, 273, pp. 15487-15493. [INFOTRIEVE] [CSA] [CROSSREF]
197. Sudhakar, A. and Sugimoto, H. and Yang, C. and Lively, J. and Zeisberg, M. and Kalluri, R. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins Proceedings of the National Academy of Sciences of the United States of America, 100, pp. 4766-4771. [INFOTRIEVE] [CSA] [CROSSREF]
198. Sun, J. and Wang, D. and Jain, R. and Carie, A. and Paquette, S. and Ennis, E. and Blaskovich, M. and Baldini, L. and Coppola, D. and Hamilton, A. and (2005) Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors Oncogene, 24, pp. 4701-4709. [INFOTRIEVE] [CSA] [CROSSREF]
199. Takayama, Y. and May, P. and Anderson, R. and Herz, J. (2005) Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta) Journal of Biological Chemistry, 280, pp. 18504-18510. [INFOTRIEVE] [CSA] [CROSSREF]
200. Take, M. and Tsutsui, J. and Obama, H. and Ozawa, M. and Nakayama, T. and Maruyama, I. and Arima, T. and Muramatsu, T. (1994) Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM) Journal of Biochemistry (Tokyo), 116, pp. 1063-1068. [CSA]
201. Tanghetti, E. and Ria, R. and Dell'Era, P. and Urbinati, C. and Rusnati, M. and Ennas, M. and Presta, M. (2002) Biological activity of substrate-bound basic fibroblast growth factor (FGF2): Recruitment of FGF receptor-1 in endothelial cell adhesion contacts Oncogene, 21, pp. 3889-3897. [INFOTRIEVE] [CSA] [CROSSREF]
202. Taraboletti, G. and Belotti, D. and Borsotti, P. and Vergani, V. and Rusnati, M. and Presta, M. and Giavazzi, R. (1997) The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor Cell Growth and Differentiation, 8, pp. 471-479. [INFOTRIEVE] [CSA]
203. Taraboletti, G. and Benelli, R. and Borsotti, P. and Rusnati, M. and Presta, M. and Giavazzi, R. and Ruco, L. and Albini, A. (1999) Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions Journal of Pathology, 188, pp. 76-81. [INFOTRIEVE] [CSA] [CROSSREF]
204. Tarui, T. and Miles, L. and Takada, Y. (2001) Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells Journal of Biological Chemistry, 276, pp. 39562-39568. [INFOTRIEVE] [CSA]
205. Taylor, J. and Cupp, C. and Diaz, A. and Chowdhury, M. and Khalili, K. and Jimenez, S. and Amini, S. (1992) Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 9617-9621. [INFOTRIEVE] [CSA]
206. Tessler, S. and Rockwell, P. and Hicklin, D. and Cohen, T. and Levi, B. and Witte, L. and Lemischka, I. and Neufeld, G. (1994) Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors Journal of Biological Chemistry, 269, pp. 12456-12461. [INFOTRIEVE] [CSA]
207. Tezono, K. and Sarker, K. and Kikuchi, H. and Nasu, M. and Kitajima, I. and Maruyama, I. (2001) Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: Production of IL-6 and IL-8 in monocytes by fibrin clots Haemostasis, 31, pp. 71-79. [INFOTRIEVE] [CSA] [CROSSREF]
208. Tiesman, J. and Hart, C. (1993) Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma Journal of Biological Chemistry, 268, pp. 9621-9628. [INFOTRIEVE] [CSA]
209. Tseng, W. and Huang, S. and Huang, J. (2004) LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells FEBS Letters, 562, pp. 71-78. [INFOTRIEVE] [CSA] [CROSSREF]
210. Tufvesson, E. and Westergren-Thorsson, G. (2002) Tumour necrosis factor-alpha interacts with biglycan and decorin FEBS Letters, 530, pp. 124-128. [INFOTRIEVE] [CSA] [CROSSREF]
211. Turnbull, J. and Powell, A. and Guimond, S. (2001) Heparan sulfate: Decoding a dynamic multifunctional cell regulator Trends in Cell Biology, 11, pp. 75-82. [INFOTRIEVE] [CSA] [CROSSREF]
212. Tyagi, M. and Rusnati, M. and Presta, M. and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans Journal of Biological Chemistry, 276, pp. 3254-3261. [INFOTRIEVE] [CSA] [CROSSREF]
213. Ueno, H. and Gunn, M. and Dell, K. and Tseng, A., Jr. and Williams, L. (1992) A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor Journal of Biological Chemistry, 267, pp. 1470-1476. [INFOTRIEVE] [CSA]
214. Uetz, P. and Giot, L. and Cagney, G. and Mansfield, T. and Judson, R. and Knight, J. and Lockshon, D. and Narayan, V. and Srinivasan, M. and Pochart, P. and (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae Nature, 403, pp. 623-627. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
215. Urbinati, C. and Bugatti, A. and Giacca, M. and Schlaepfer, D. and Presta, M. and Rusnati, M. (2005a) alpha v beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappa B activation and motogenic activity by HIV-1 Tat in endothelial cells Journal of Cell Science, 118, pp. 3949-3958. [INFOTRIEVE] [CSA] [CROSSREF]
216. Urbinati, C. and Mitola, S. and Tanghetti, E. and Kumar, C. and Waltenberger, J. and Ribatti, D. and Presta, M. and Rusnati, M. (2005b) Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo Arteriosclerosis Thrombosis and Vascular Biology, 25, pp. 2315-2320. [CSA] [CROSSREF]
217. Urbinati, C. and Bugatti, A. and Oreste, P. and Zoppetti, G. and Waltenberger, J. and Mitola, S. and Ribatti, D. and Presta, M. and Rusnati, M. (2004) Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists FEBS Letters, 568, pp. 171-177. [INFOTRIEVE] [CSA] [CROSSREF]
218. Urbinati, C. and Mitola, S. and Tanghetti, E. and Kumar, C. and Waltenberger, J. and Ribatti, D. and Presta, M. and Rusnati, M. (2005c) Integrin aVb3 as a target for blocking HIV-1 Tat induced endothelial cell activation in vitro and angiogenesis in vivo Arteriosclerosis, Thrombosis, and Vascular Biology. in press [CSA]
219. Vilchis-Landeros, M. and Montiel, J. and Mendoza, V. and Mendoza-Hernandez, G. and Lopez-Casillas, F. (2001) Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent Biochemical Journal, 355, pp. 215-222. [INFOTRIEVE] [CSA] [CROSSREF]
220. Vlahakis, N. and Young, B. and Atakilit, A. and Sheppard, D. (2005) The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 Journal of Biological Chemistry, 280, pp. 4544-4552. [INFOTRIEVE] [CSA] [CROSSREF]
221. Vlodavsky, I. and Friedmann, Y. (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis Journal of Clinical Investigation, 108, pp. 341-347. [INFOTRIEVE] [CSA] [CROSSREF]
222. Vlodavsky, I. and Korner, G. and Ishai-Michaeli, R. and Bashkin, P. and Bar-Shavit, R. and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis Cancer and Metastasis Reviews, 9, pp. 203-226. [INFOTRIEVE] [CSA] [CROSSREF]
223. Vogel, B. and Lee, S. and Hildebrand, A. and Craig, W. and Pierschbacher, M. and Wong-Staal, F. and Ruoslahti, E. (1993) A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin Journal of Cell Biology, 121, pp. 461-468. [INFOTRIEVE] [CSA] [CROSSREF]
224. Wajih, N. and Walter, J. and Sane, D. (2002) Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met) Circulation Research, 90, pp. 46-52. [INFOTRIEVE] [CSA] [CROSSREF]
225. Webb, D. and Atkins, T. and Crookston, K. and Burmester, J. and Qian, S. and Gonias, S. (1994) Transforming growth factor beta isoform 2-specific high affinity binding to native alpha 2-macroglobulin. Chimeras identify a sequence that determines affinity for native but not activated alpha 2-macroglobulin Journal of Biological Chemistry, 269, pp. 30402-30406. [INFOTRIEVE] [CSA]
226. West, D. and Rees, C. and Duchesne, L. and Patey, S. and Terry, C. and Turnbull, J. and Delehedde, M. and Heegaard, C. and Allain, F. and Vanpouille, C. and (2005) Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2 Journal of Biological Chemistry, 280, pp. 13457-13464. [INFOTRIEVE] [CSA] [CROSSREF]
227. Whitelock, J. and Murdoch, A. and Iozzo, R. and Underwood, P. (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases Journal of Biological Chemistry, 271, pp. 10079-10086. [INFOTRIEVE] [CSA] [CROSSREF]
228. Xu, Y. and Liu, Y. and Yu, Q. (2004) Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans Journal of Biological Chemistry, 279, pp. 41179-41188. [INFOTRIEVE] [CSA] [CROSSREF]
229. Yamazaki, Y. and Matsunaga, Y. and Nakano, Y. and Morita, T. (2005) Identification of VEGF receptor-binding protein in the venom of eastern cottonmouth: A new role of snake venom myotoxic Lys49-phospholipase A2 Journal of Biological Chemistry, 280, pp. 29989-29992. [INFOTRIEVE] [CSA] [CROSSREF]
230. Yang, S. and Kwon, B. and Gho, Y. and Chae, C. (2005) Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity Journal of Neurochemistry, 93, pp. 118-127. [INFOTRIEVE] [CSA] [CROSSREF]
231. Zhang, N. and Deuel, T. (1999) Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors Current Opinion in Hematology, 6, pp. 44-50. [INFOTRIEVE] [CSA] [CROSSREF]
232. Zioncheck, T. and Richardson, L. and Liu, J. and Chang, L. and King, K. and Bennett, G. and Fugedi, P. and Chamow, S. and Schwall, R. and Stack, R. (1995) Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity Journal of Biological Chemistry, 270, pp. 16871-16878. [INFOTRIEVE] [CSA] [CROSSREF]